{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:28:46Z","timestamp":1744172926505,"version":"3.40.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","award":["SZSM202211020"],"award-info":[{"award-number":["SZSM202211020"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100019595","name":"Youth and Middle-aged Scientific and Technological Innovation Leading Talents Program of the Corps","doi-asserted-by":"publisher","award":["BJHPA-2022-SHZHYXZHQNYJ-LCH-003"],"award-info":[{"award-number":["BJHPA-2022-SHZHYXZHQNYJ-LCH-003"]}],"id":[{"id":"10.13039\/501100019595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s43032-024-01756-9","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T15:42:03Z","timestamp":1733326923000},"page":"1362-1371","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Embryo Cryopreservation Strategy May Improve Live Birth for Women Underwent In Vitro Maturation After Early Oocyte Retrieval: A Retrospective Cohort Study"],"prefix":"10.1007","volume":"32","author":[{"given":"Chunyan","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2156-1483","authenticated-orcid":false,"given":"Lei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbo","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"issue":"1","key":"1756_CR1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/humrep\/deu248","volume":"30","author":"ML Walls","year":"2015","unstructured":"Walls ML, et al. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes. Hum Reprod. 2015;30(1):88\u201396.","journal-title":"Hum Reprod"},{"issue":"12","key":"1756_CR2","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.3390\/biomedicines9121904","volume":"9","author":"H Yang","year":"2021","unstructured":"Yang H, et al. Factors Influencing the In Vitro Maturation (IVM) of Human Oocyte. Biomedicines. 2021;9(12):1904.","journal-title":"Biomedicines"},{"issue":"1","key":"1756_CR3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.fertnstert.2014.04.010","volume":"102","author":"DE Reichman","year":"2014","unstructured":"Reichman DE, et al. Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles. Fertil Steril. 2014;102(1):99\u2013102.","journal-title":"Fertil Steril"},{"issue":"3","key":"1756_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1530\/JOE-15-0246","volume":"226","author":"YG Wu","year":"2015","unstructured":"Wu YG, et al. Aging-related premature luteinization of granulosa cells is avoided by early oocyte retrieval. J Endocrinol. 2015;226(3):167\u201380.","journal-title":"J Endocrinol"},{"issue":"1","key":"1756_CR5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12958-023-01110-9","volume":"21","author":"R Gan","year":"2023","unstructured":"Gan R, et al. Time interval between hCG administration and oocyte retrieval and ART outcomes: an updated systematic review and meta-analysis. Reprod Biol Endocrinol. 2023;21(1):61.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"1756_CR6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4183\/aeb.2021.106","volume":"17","author":"S Findeklee","year":"2021","unstructured":"Findeklee S, Hachenberg J, Kienast K. In vitro maturation of oocytes with consecutive clinical pregnancy after accidental premature ovulation induction-a rescue strategy in art. Acta Endocrinol (Buchar). 2021;17(1):106\u201310.","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"1","key":"1756_CR7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13048-018-0469-x","volume":"11","author":"X Lu","year":"2018","unstructured":"Lu X, et al. Decrease in preovulatory serum estradiol is a valuable marker for predicting premature ovulation in natural\/unstimulated in vitro fertilization cycle. J Ovarian Res. 2018;11(1):96.","journal-title":"J Ovarian Res"},{"issue":"2","key":"1756_CR8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/humupd\/8.2.129","volume":"8","author":"MJ Pelinck","year":"2002","unstructured":"Pelinck MJ, et al. Efficacy of natural cycle IVF: a review of the literature. Hum Reprod Update. 2002;8(2):129\u201339.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"1756_CR9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0015-0282(16)56891-5","volume":"62","author":"A Trounson","year":"1994","unstructured":"Trounson A, Wood C, Kausche A. In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril. 1994;62(2):353\u201362.","journal-title":"Fertil Steril"},{"issue":"4","key":"1756_CR10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.fertnstert.2017.08.020","volume":"108","author":"ZY Yang","year":"2017","unstructured":"Yang ZY, Chian RC. Development of in vitro maturation techniques for clinical applications. Fertil Steril. 2017;108(4):577\u201384.","journal-title":"Fertil Steril"},{"issue":"4","key":"1756_CR11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.fertnstert.2023.02.010","volume":"119","author":"RB Gilchrist","year":"2023","unstructured":"Gilchrist RB, Smitz J. Oocyte in vitro maturation: physiological basis and application to clinical practice. Fertil Steril. 2023;119(4):524\u201339.","journal-title":"Fertil Steril"},{"issue":"2","key":"1756_CR12","doi-asserted-by":"crossref","first-page":"hoz034","DOI":"10.1093\/hropen\/hoz034","volume":"2020","author":"SC Braam","year":"2020","unstructured":"Braam SC, et al. The perspective of women with an increased risk of OHSS regarding the safety and burden of IVF: a discrete choice experiment. Hum Reprod Open. 2020;2020(2):hoz034.","journal-title":"Hum Reprod Open"},{"issue":"4","key":"1756_CR13","first-page":"665","volume":"100","author":"TJ Child","year":"2002","unstructured":"Child TJ, et al. A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries. Obstet Gynecol. 2002;100(4):665\u201370.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"1756_CR14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fertnstert.2012.04.046","volume":"98","author":"AS Gremeau","year":"2012","unstructured":"Gremeau AS, et al. In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles. Fertil Steril. 2012;98(2):355\u201360.","journal-title":"Fertil Steril"},{"issue":"1","key":"1756_CR15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/humrep\/deu248","volume":"30","author":"ML Walls","year":"2014","unstructured":"Walls ML, et al. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes. Hum Reprod. 2014;30(1):88\u201396.","journal-title":"Hum Reprod"},{"issue":"1","key":"1756_CR16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","volume":"104","author":"Y Kuang","year":"2015","unstructured":"Kuang Y, et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 2015;104(1):62-70.e3.","journal-title":"Fertil Steril"},{"key":"1756_CR17","doi-asserted-by":"crossref","first-page":"758896","DOI":"10.3389\/fendo.2021.758896","volume":"12","author":"H Xu","year":"2021","unstructured":"Xu H, et al. GnRH antagonist protocol with cessation of cetrorelix on trigger day improves embryological outcomes for patients with sufficient ovarian reserve. Front Endocrinol (Lausanne). 2021;12:758896.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1756_CR18","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3389\/fendo.2018.00767","volume":"9","author":"D Zhang","year":"2018","unstructured":"Zhang D, et al. Flexible low-dose GnRH antagonist protocol is effective in patients with sufficient ovarian reserve in IVF. Front Endocrinol (Lausanne). 2018;9:767.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1756_CR19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.fertnstert.2011.07.1108","volume":"96","author":"M De Vos","year":"2011","unstructured":"De Vos M, et al. Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome. Fertil Steril. 2011;96(4):860\u20134.","journal-title":"Fertil Steril"},{"issue":"1","key":"1756_CR20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.fertnstert.2006.08.092","volume":"89","author":"BS Shapiro","year":"2008","unstructured":"Shapiro BS, et al. Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day 5 or day 6 blastocysts may reflect differences in embryo-endometrium synchrony. Fertil Steril. 2008;89(1):20\u20136.","journal-title":"Fertil Steril"},{"issue":"2","key":"1756_CR21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.fertnstert.2011.05.050","volume":"96","author":"BS Shapiro","year":"2011","unstructured":"Shapiro BS, et al. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders. Fertil Steril. 2011;96(2):344\u20138.","journal-title":"Fertil Steril"},{"issue":"5","key":"1756_CR22","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.fertnstert.2015.07.1148","volume":"104","author":"PS Uzelac","year":"2015","unstructured":"Uzelac PS, et al. Live birth following in vitro maturation of oocytes retrieved from extracorporeal ovarian tissue aspiration and embryo cryopreservation for 5 years. Fertil Steril. 2015;104(5):1258\u201360.","journal-title":"Fertil Steril"},{"issue":"2","key":"1756_CR23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/jhrs.JHRS_93_16","volume":"10","author":"M Mohsenzadeh","year":"2017","unstructured":"Mohsenzadeh M, et al. Embryo cryopreservation following in-vitro maturation for fertility preservation in a woman with Mullerian adenosarcoma: a case report. J Hum Reprod Sci. 2017;10(2):138\u201341.","journal-title":"J Hum Reprod Sci"},{"issue":"3","key":"1756_CR24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.fertnstert.2017.07.006","volume":"108","author":"Z Qiong","year":"2017","unstructured":"Qiong Z, et al. Clinical validation of pinopode as a marker of endometrial receptivity: a randomized controlled trial. Fertil Steril. 2017;108(3):513-517.e2.","journal-title":"Fertil Steril"},{"issue":"6","key":"1756_CR25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/humupd\/dmg045","volume":"9","author":"C Bourgain","year":"2003","unstructured":"Bourgain C, Devroey P. The endometrium in stimulated cycles for IVF. Hum Reprod Update. 2003;9(6):515\u201322.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"1756_CR26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0015-0282(97)80080-5","volume":"67","author":"F Ubaldi","year":"1997","unstructured":"Ubaldi F, et al. Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril. 1997;67(3):521\u20136.","journal-title":"Fertil Steril"},{"issue":"1","key":"1756_CR27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/humrep\/10.1.4","volume":"10","author":"D de Ziegler","year":"1995","unstructured":"de Ziegler D. Hormonal control of endometrial receptivity. Hum Reprod. 1995;10(1):4\u20137.","journal-title":"Hum Reprod"},{"issue":"6","key":"1756_CR28","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0015-0282(99)00137-5","volume":"71","author":"OH Develioglu","year":"1999","unstructured":"Develioglu OH, et al. Endometrial estrogen and progesterone receptor and pinopode expression in stimulated cycles of oocyte donors. Fertil Steril. 1999;71(6):1040\u20137.","journal-title":"Fertil Steril"},{"issue":"4","key":"1756_CR29","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0015-0282(16)56221-9","volume":"60","author":"GE Hofmann","year":"1993","unstructured":"Hofmann GE, et al. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril. 1993;60(4):675\u20139.","journal-title":"Fertil Steril"},{"issue":"2","key":"1756_CR30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0015-0282(97)81518-X","volume":"68","author":"RJ Chetkowski","year":"1997","unstructured":"Chetkowski RJ, Kiltz RJ, Salyer WR. In premature luteinization, progesterone induces secretory transformation of the endometrium without impairment of embryo viability. Fertil Steril. 1997;68(2):292\u20137.","journal-title":"Fertil Steril"},{"issue":"4","key":"1756_CR31","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.fertnstert.2016.02.030","volume":"105","author":"JM Franasiak","year":"2016","unstructured":"Franasiak JM, et al. Both slowly developing embryos and a variable pace of luteal endometrial progression may conspire to prevent normal birth in spite of a capable embryo. Fertil Steril. 2016;105(4):861\u20136.","journal-title":"Fertil Steril"},{"issue":"1","key":"1756_CR32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ogc.2014.10.003","volume":"42","author":"TB Mesen","year":"2015","unstructured":"Mesen TB, Young SL. Progesterone and the luteal phase: a requisite to reproduction. Obstet Gynecol Clin North Am. 2015;42(1):135\u201351.","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"6","key":"1756_CR33","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/humrep\/det055","volume":"28","author":"J Evans","year":"2013","unstructured":"Evans J, Salamonsen LA. Too much of a good thing? Experimental evidence suggests prolonged exposure to hCG is detrimental to endometrial receptivity. Hum Reprod. 2013;28(6):1610\u20139.","journal-title":"Hum Reprod"},{"issue":"9","key":"1756_CR34","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1177\/1933719113477486","volume":"20","author":"WA Palomino","year":"2013","unstructured":"Palomino WA, et al. Complement C3 and decay-accelerating factor expression levels are modulated by human chorionic gonadotropin in endometrial compartments during the implantation window. Reprod Sci. 2013;20(9):1103\u201310.","journal-title":"Reprod Sci"},{"issue":"11","key":"1756_CR35","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s10815-016-0773-6","volume":"33","author":"WT Teh","year":"2016","unstructured":"Teh WT, McBain J, Rogers P. What is the contribution of embryo-endometrial asynchrony to implantation failure? J Assist Reprod Genet. 2016;33(11):1419\u201330.","journal-title":"J Assist Reprod Genet"},{"issue":"7","key":"1756_CR36","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/humrep\/dead097","volume":"38","author":"S Batha","year":"2023","unstructured":"Batha S, et al. Day after rescue ICSI: eliminating total fertilization failure after conventional IVF with high live birth rates following cryopreserved blastocyst transfer. Hum Reprod. 2023;38(7):1277\u201383.","journal-title":"Hum Reprod"},{"issue":"23","key":"1756_CR37","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJM199906103402304","volume":"340","author":"AJ Wilcox","year":"1999","unstructured":"Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med. 1999;340(23):1796\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"1756_CR38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1530\/jrf.0.0920497","volume":"92","author":"JP Hearn","year":"1991","unstructured":"Hearn JP, Webley GE, Gidley-Baird AA. Chorionic gonadotrophin and embryo-maternal recognition during the peri-implantation period in primates. J Reprod Fertil. 1991;92(2):497\u2013509.","journal-title":"J Reprod Fertil"},{"issue":"6","key":"1756_CR39","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1071\/RD9951395","volume":"7","author":"PA Rogers","year":"1995","unstructured":"Rogers PA. Current studies on human implantation: a brief overview. Reprod Fertil Dev. 1995;7(6):1395\u20139.","journal-title":"Reprod Fertil Dev"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-024-01756-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-024-01756-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-024-01756-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:51:34Z","timestamp":1744149094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-024-01756-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1756"],"URL":"https:\/\/doi.org\/10.1007\/s43032-024-01756-9","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"type":"print","value":"1933-7191"},{"type":"electronic","value":"1933-7205"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"29 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Reproductive Hospital Affiliated to Shandong University Institutional Review Board (IRB) before study initiation. Written informed consent was obtained from the participants when they presented for IVF-ICSI treatment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interests"}}]}}